BioNexus Gene Lab Corp - 8-K Filing

BioNexus Gene Lab Corp advances VitaGuard™ commercialization in Southeast Asia following China working visit (Items: 8.01 Other Events On July 28, 2026, BioNexus Gene Lab Corp, 9.01 Financial Statement and Exhibits)

SEC EDGAR ·

Tickers: $BGLC

Read the full article at SEC EDGAR

More Regulatory news